reference/28195068

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/28195068

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase II\|Journal Article\|Research Support, Non-U.S. Gov't
endingPage	212
issn	1525-1470 0736-8046
issueIdentifier	2
pageRange	203-212
publicationName	Pediatric Dermatology
startingPage	203
bibliographicCitation	McCuaig CC, Dubois J, Powell J, Belleville C, David M, Rousseau E, Gendron R, Jafarian F, Auger I. A phase II, open-label study of the efficacy and safety of imiquimod in the treatment of superficial and mixed infantile hemangioma. Pediatr Dermatol. 2009 Mar;26(2):203–12. doi: 10.1111/j.1525-1470.2008.00857.x. PMID: 19419474.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_824227bbbd443c1dacedfe8635d7c0ea http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ded9d5ad641ace75a12f8a372ada3b36 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a3e96a27e64ef4d26628f47583273755 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fff407d310bbac4e08549fadb9daeb8d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c2581b21cfaa6792e02506ba8284ceed http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_44914b27097a90105c6acc16471cfd71 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_50a3c4ec48d190dc65a4b74d8011159d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f2b33a5b2010b13028ff20dbfbf1120c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_795001c3dcbf650e0e03cacd6dfb3d8f
date	200903
identifier	https://doi.org/10.1111/j.1525-1470.2008.00857.x https://pubmed.ncbi.nlm.nih.gov/19419474
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/6552 https://portal.issn.org/resource/ISSN/1525-1470 https://portal.issn.org/resource/ISSN/0736-8046
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	A Phase II, Open‐Label Study of the Efficacy and Safety of Imiquimod in the Treatment of Superficial and Mixed Infantile Hemangioma
discusses	http://id.nlm.nih.gov/mesh/M0000967 http://id.nlm.nih.gov/mesh/M0024770 http://id.nlm.nih.gov/mesh/M0356369 http://id.nlm.nih.gov/mesh/M0158430 http://id.nlm.nih.gov/mesh/M0025711 http://id.nlm.nih.gov/mesh/M0001483
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D006391Q000188 http://id.nlm.nih.gov/mesh/D000634Q000627 http://id.nlm.nih.gov/mesh/D012878Q000188 http://id.nlm.nih.gov/mesh/D000970Q000627
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D007223 http://id.nlm.nih.gov/mesh/D016898Q000097 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D042461Q000652 http://id.nlm.nih.gov/mesh/D000634Q000097 http://id.nlm.nih.gov/mesh/D000077271 http://id.nlm.nih.gov/mesh/D016222Q000097 http://id.nlm.nih.gov/mesh/D000287 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D000970Q000097 http://id.nlm.nih.gov/mesh/D042461Q000097
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7939 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10232 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57469 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7635

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127765602

Total number of triples: 55.